Detectability of T-measurable diseases in advanced gastric cancer on FDG PET-CT

Sun Young Oh, Gi Jeong Cheon, Young Chul Kim, Eugene Jeong, Seungeun Kim, Jae-Gol Choe

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose Usefulness of FDG PET-CT in monitoring response in locally advanced gastric cancer has been reported. The purpose of this study was to evaluate the related factors to detect measurable diseases in advanced gastric cancer on FDG PET-CT. Methods We retrospectively reviewed 38 patients diagnosed as having advanced gastric cancer. We defined the measurable diseases when there was visualized tumor of which maximum standardized uptake value (SUVmax) was higher than 1.35*SUVmax of liver + 2*SD of liver SUV. We evaluated what kinds of factors from the clinicopathologic features were related to identifying measurable diseases. Results Of 38 patients with advanced gastric cancer, 18 (50 %) had measurable tumors on FDG PET-CT. Measurable tumors were significantly more frequent in well or moderately differentiated adenocarcinoma (70.5 % vs 35.3 %, p<0.05), in the tumors located at antrum or angle (66.7 % vs 29.4 %, p<0.05) and in the elderly group (age of 55 years old or more, 72.0 % vs 8.3 %, p<0.001) than the others, respectively. By multivariate analysis, age at diagnosis was the only independent predictor for the measurable disease on FDG PET-CT. Conclusion We found that age at diagnosis, as well as histologic types and location of tumors, were the affecting factors to detect measurable disease on FDG PET-CT in patients with advanced gastric cancer. Our study suggests that elderly patients of age of 55 years old or more can frequently have T-measurable disease on FDG PET-CT in advanced gastric cancer and FDG PET-CT will be helpful to monitor measurable disease.

Original languageEnglish
Pages (from-to)261-268
Number of pages8
JournalNuclear Medicine and Molecular Imaging
Volume46
Issue number4
DOIs
Publication statusPublished - 2012 Dec 1

Fingerprint

Stomach Neoplasms
Neoplasms
Liver
Positron Emission Tomography Computed Tomography
Adenocarcinoma
Multivariate Analysis
Age Groups

Keywords

  • Advanced gastric cancer
  • Affecting factor
  • Age at diagnosis
  • FDG PET-CT
  • Measurable disease

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Detectability of T-measurable diseases in advanced gastric cancer on FDG PET-CT. / Oh, Sun Young; Cheon, Gi Jeong; Kim, Young Chul; Jeong, Eugene; Kim, Seungeun; Choe, Jae-Gol.

In: Nuclear Medicine and Molecular Imaging, Vol. 46, No. 4, 01.12.2012, p. 261-268.

Research output: Contribution to journalArticle

Oh, Sun Young ; Cheon, Gi Jeong ; Kim, Young Chul ; Jeong, Eugene ; Kim, Seungeun ; Choe, Jae-Gol. / Detectability of T-measurable diseases in advanced gastric cancer on FDG PET-CT. In: Nuclear Medicine and Molecular Imaging. 2012 ; Vol. 46, No. 4. pp. 261-268.
@article{09568479aacf40bbb6c18e0ee9585ddb,
title = "Detectability of T-measurable diseases in advanced gastric cancer on FDG PET-CT",
abstract = "Purpose Usefulness of FDG PET-CT in monitoring response in locally advanced gastric cancer has been reported. The purpose of this study was to evaluate the related factors to detect measurable diseases in advanced gastric cancer on FDG PET-CT. Methods We retrospectively reviewed 38 patients diagnosed as having advanced gastric cancer. We defined the measurable diseases when there was visualized tumor of which maximum standardized uptake value (SUVmax) was higher than 1.35*SUVmax of liver + 2*SD of liver SUV. We evaluated what kinds of factors from the clinicopathologic features were related to identifying measurable diseases. Results Of 38 patients with advanced gastric cancer, 18 (50 {\%}) had measurable tumors on FDG PET-CT. Measurable tumors were significantly more frequent in well or moderately differentiated adenocarcinoma (70.5 {\%} vs 35.3 {\%}, p<0.05), in the tumors located at antrum or angle (66.7 {\%} vs 29.4 {\%}, p<0.05) and in the elderly group (age of 55 years old or more, 72.0 {\%} vs 8.3 {\%}, p<0.001) than the others, respectively. By multivariate analysis, age at diagnosis was the only independent predictor for the measurable disease on FDG PET-CT. Conclusion We found that age at diagnosis, as well as histologic types and location of tumors, were the affecting factors to detect measurable disease on FDG PET-CT in patients with advanced gastric cancer. Our study suggests that elderly patients of age of 55 years old or more can frequently have T-measurable disease on FDG PET-CT in advanced gastric cancer and FDG PET-CT will be helpful to monitor measurable disease.",
keywords = "Advanced gastric cancer, Affecting factor, Age at diagnosis, FDG PET-CT, Measurable disease",
author = "Oh, {Sun Young} and Cheon, {Gi Jeong} and Kim, {Young Chul} and Eugene Jeong and Seungeun Kim and Jae-Gol Choe",
year = "2012",
month = "12",
day = "1",
doi = "10.1007/s13139-012-0149-5",
language = "English",
volume = "46",
pages = "261--268",
journal = "Nuclear Medicine and Molecular Imaging",
issn = "1869-3474",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Detectability of T-measurable diseases in advanced gastric cancer on FDG PET-CT

AU - Oh, Sun Young

AU - Cheon, Gi Jeong

AU - Kim, Young Chul

AU - Jeong, Eugene

AU - Kim, Seungeun

AU - Choe, Jae-Gol

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Purpose Usefulness of FDG PET-CT in monitoring response in locally advanced gastric cancer has been reported. The purpose of this study was to evaluate the related factors to detect measurable diseases in advanced gastric cancer on FDG PET-CT. Methods We retrospectively reviewed 38 patients diagnosed as having advanced gastric cancer. We defined the measurable diseases when there was visualized tumor of which maximum standardized uptake value (SUVmax) was higher than 1.35*SUVmax of liver + 2*SD of liver SUV. We evaluated what kinds of factors from the clinicopathologic features were related to identifying measurable diseases. Results Of 38 patients with advanced gastric cancer, 18 (50 %) had measurable tumors on FDG PET-CT. Measurable tumors were significantly more frequent in well or moderately differentiated adenocarcinoma (70.5 % vs 35.3 %, p<0.05), in the tumors located at antrum or angle (66.7 % vs 29.4 %, p<0.05) and in the elderly group (age of 55 years old or more, 72.0 % vs 8.3 %, p<0.001) than the others, respectively. By multivariate analysis, age at diagnosis was the only independent predictor for the measurable disease on FDG PET-CT. Conclusion We found that age at diagnosis, as well as histologic types and location of tumors, were the affecting factors to detect measurable disease on FDG PET-CT in patients with advanced gastric cancer. Our study suggests that elderly patients of age of 55 years old or more can frequently have T-measurable disease on FDG PET-CT in advanced gastric cancer and FDG PET-CT will be helpful to monitor measurable disease.

AB - Purpose Usefulness of FDG PET-CT in monitoring response in locally advanced gastric cancer has been reported. The purpose of this study was to evaluate the related factors to detect measurable diseases in advanced gastric cancer on FDG PET-CT. Methods We retrospectively reviewed 38 patients diagnosed as having advanced gastric cancer. We defined the measurable diseases when there was visualized tumor of which maximum standardized uptake value (SUVmax) was higher than 1.35*SUVmax of liver + 2*SD of liver SUV. We evaluated what kinds of factors from the clinicopathologic features were related to identifying measurable diseases. Results Of 38 patients with advanced gastric cancer, 18 (50 %) had measurable tumors on FDG PET-CT. Measurable tumors were significantly more frequent in well or moderately differentiated adenocarcinoma (70.5 % vs 35.3 %, p<0.05), in the tumors located at antrum or angle (66.7 % vs 29.4 %, p<0.05) and in the elderly group (age of 55 years old or more, 72.0 % vs 8.3 %, p<0.001) than the others, respectively. By multivariate analysis, age at diagnosis was the only independent predictor for the measurable disease on FDG PET-CT. Conclusion We found that age at diagnosis, as well as histologic types and location of tumors, were the affecting factors to detect measurable disease on FDG PET-CT in patients with advanced gastric cancer. Our study suggests that elderly patients of age of 55 years old or more can frequently have T-measurable disease on FDG PET-CT in advanced gastric cancer and FDG PET-CT will be helpful to monitor measurable disease.

KW - Advanced gastric cancer

KW - Affecting factor

KW - Age at diagnosis

KW - FDG PET-CT

KW - Measurable disease

UR - http://www.scopus.com/inward/record.url?scp=84875461021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875461021&partnerID=8YFLogxK

U2 - 10.1007/s13139-012-0149-5

DO - 10.1007/s13139-012-0149-5

M3 - Article

AN - SCOPUS:84875461021

VL - 46

SP - 261

EP - 268

JO - Nuclear Medicine and Molecular Imaging

JF - Nuclear Medicine and Molecular Imaging

SN - 1869-3474

IS - 4

ER -